Initially intended for larger University Research Groups involved in Radiation Biology and Imaging, SARRP has now been adopted by small laboratories enabling research into regenerative medicine and radiation oncology. SARRP utilises advanced robotics and On Board Cone-Beam CT to target specific organs, thus enabling pinpoint radiation of tumours in murine models. The unique geometry and rotating animal stage assists researchers in delivering non-coplanar beams, which together with the fast calculating dose planning system results in much better dose distributions while avoiding organs at risk. Researchers can now model both advanced radio surgical and standard clinical practices to enhance radiation oncology research.

Adrian Treverton, Xstrahl Sales Director, says, "The 20th SARRP landmark is a stamp of aprpoval for this technique and Xstrahl's SARRP irradiator. There are many ground breaking research papers currently published utiilising SARRP which enables the benefits derived by scientists using the system. SARRP is designed for biologists - the simple intuitive design in addition to our application support team enables researchers to work constructively and quickly on experiments. With platforms in the USA, Canada, Europe and Asia, SARRP is now the most advanced system available for radio biological research."

SARRP enables both Physics groups and Biologists to replicate treatment within in vivo models. The additional ability to pinpoint an exact target with radiation is spearheading research into many areas including stem cell and generative medicine, combination therapies and cardiovascular research. SARRP enables this treatment modality to be pre-clincially evaluated to support pioneering medicine. Effective use of radiation is already changing the lives of cancer patients.
Amanda Tulk, Xstrahl's Business Development Director, adds, "Xstrahl collaborates with many different research groups throughout the world. The SARRP consortium is addressing a multitude of new developments from micro-dosimetry, fluorescence tomography and gating. These developments enable researchers to better understand the mechanisms of DNA damage and repair by delivering radiation with 0.2 mm accuracy to anatomical targets.

Xstrahl encourages many groups to work together with Johns Hopkins University to develop joint research and share common ideas. Having multiple groups contributing to system development has really enabled SARRP to continue to grow, whilst still maintaining the elegance and ease of a true laboratory instrument."

Xstrahl is a leading designer and manufacturer of X-Ray solutions employed by both medical radiotherapy centres treating superficial skin conditions and cancers and life science researchers working in radiation biology research. Xstrahl collaborates with researchers on imaging and dose delivery research systems, which assist the researcher to better understand the effect of targeted radiation, therefore enhancing the understanding of how radiation interacts with tissue; the mechanisms of DNA repair and further, how radiation can be employed to effectively enhance personalised medicine.

More HCB News